IBS Subtypes and Diagnosis: Rome IV and Colonoscopy | MDster You are offline Back online! [ ](/) Specialities [ Anesthesiology ](https://mdster.com/speciality/anesthesiology) [ Emergency Medicine ](https://mdster.com/speciality/emergency-medicine) [ Family Medicine ](https://mdster.com/speciality/family-medicine) [ Internal Medicine ](https://mdster.com/speciality/internal-medicine) [ Obstetrics & Gynecology ](https://mdster.com/speciality/obstetrics-gynecology) [ Pediatrics ](https://mdster.com/speciality/pediatrics) [ Psychiatry ](https://mdster.com/speciality/psychiatry) [ Features ](https://mdster.com/features) [ Pricing ](https://mdster.com/pricing) [ Blog ](https://mdster.com/blog) Menu Specialities [ Anesthesiology ](https://mdster.com/speciality/anesthesiology) [ Emergency Medicine ](https://mdster.com/speciality/emergency-medicine) [ Family Medicine ](https://mdster.com/speciality/family-medicine) [ Internal Medicine ](https://mdster.com/speciality/internal-medicine) [ Obstetrics & Gynecology ](https://mdster.com/speciality/obstetrics-gynecology) [ Pediatrics ](https://mdster.com/speciality/pediatrics) [ Psychiatry ](https://mdster.com/speciality/psychiatry) [ Features ](https://mdster.com/features) [ Pricing ](https://mdster.com/pricing) [ Blog ](https://mdster.com/blog) [ Login ](https://mdster.com/auth/login) 1. [ Home ](https://mdster.com) 2. [ Blog ](https://mdster.com/blog) 3. [ Medical Education ](https://mdster.com/blog?category=medical-education) 4. IBS Subtypes and Diagnosis: Rome IV, IBS-C/D, and Colonoscopy [ Medical Education ](https://mdster.com/blog?category=medical-education) IBS Subtypes and Diagnosis: Rome IV, IBS-C/D, and Colonoscopy =============================================================== A practical Internal Medicine approach to making a positive IBS diagnosis, classifying stool pattern correctly, and knowing when a scope adds value. [ MDster Editorial Team ](https://mdster.com/about) · Apr 05, 2026 · 7 min read · 60 [ Reviewed by Dr. Ali Ragab, MBBCH, MSc, MCAI ](https://mdster.com/medical-reviewers/dr-ali-ragab) [Editorial Policy](https://mdster.com/editorial-policy) | [Corrections Policy](https://mdster.com/corrections) [ Board Review ](https://mdster.com/blog?tag=board-review) [ Internal Medicine ](https://mdster.com/blog?tag=internal-medicine) [ IBS ](https://mdster.com/blog?tag=ibs) [ Gastroenterology ](https://mdster.com/blog?tag=gastroenterology) ![IBS Subtypes and Diagnosis: Rome IV, IBS-C/D, and Colonoscopy](https://mdster.com/storage/blog/images/ibs-subtypes-and-diagnosis-rome-iv-ibs-cd-and-colonoscopy.jpg) Share this article Share this post Residents miss IBS in two opposite ways: they overdiagnose it in patients who actually have red flags, and they underdiagnose it by treating IBS as a diagnosis of exclusion that requires a colonoscopy lottery first. Both errors matter. Over-testing delays treatment and drives cost; under-thinking misses celiac disease, IBD, colorectal cancer, or a pelvic floor disorder hiding behind constipation. The high-yield move is to make a **positive diagnosis** from the history, then add only the tests that meaningfully change management. [\[1\]](#cite-1 "Reference [1]") Start With a Positive Diagnosis ------------------------------- For exam prep and current guideline-based practice as of **April 5, 2026**, the operative framework is still **Rome IV**. The ACG guideline uses Rome IV, and the Rome Foundation lists **Rome V** as coming on **June 1, 2026** rather than already in force. That distinction matters because many learners vaguely remember that IBS is about abdominal symptoms plus altered bowel habits but forget the key Rome IV point: **pain is central**. [\[1\]](#cite-1 "Reference [1]") Rome IV defines IBS as **recurrent abdominal pain**, on average at least **1 day per week in the last 3 months**, associated with at least **2 of 3** features: related to defecation, associated with a change in stool frequency, or associated with a change in stool form. Symptom onset should be at least **6 months** before diagnosis. Board pitfall: bloating, constipation, and irregular stools alone do **not** earn the diagnosis if recurrent abdominal pain is absent. In that patient, think **functional constipation** first, not IBS-C by habit. [\[1\]](#cite-1 "Reference [1]") > **Clinical Pearl:** In a constipated patient with bloating, the question is not just **How often do they stool?** Ask **Do they have recurrent abdominal pain tied to bowel habit change?** No pain, no Rome IV IBS-C. [\[1\]](#cite-1 "Reference [1]") Classify the Bowel Pattern Correctly ------------------------------------ Once the patient meets symptom criteria, subtype them using the **Bristol Stool Form Scale**—but do it properly. The ACG emphasizes that stool form should be judged only on **days with abnormal bowel movements**, ideally **off therapies** that distort stool pattern, and that a short diary gives the most accurate classification. This is where a lot of residents and board questions go wrong. [\[1\]](#cite-1 "Reference [1]") SubtypeBristol-based definitionWhy it matters**IBS-C**>25% of abnormal BMs are BSFS 1-2 and <25% are BSFS 6-7Think constipation-directed therapy and screen for evacuation disorders**IBS-D**>25% are BSFS 6-7 and <25% are BSFS 1-2Prompt celiac and inflammatory testing before you label it benign**IBS-M**>25% are BSFS 1-2 **and** >25% are BSFS 6-7Reassess the dominant current phenotype; treatment often shifts over time**IBS-U**Stool pattern does not fit the aboveRecheck diary, medication effects, and whether the history is complete Definitions are based on **abnormal stool days**, not every bowel movement the patient can remember from the last year. [\[1\]](#cite-1 "Reference [1]") Why obsess over subtyping? Because treatment tracks with subtype, and the wrong label can worsen symptoms. The guideline also notes that subtype is not fixed; more than half of patients may shift phenotype over a year. So do not fossilize the chart after one visit. **IBS-M** is especially mishandled: it is not just a patient saying, *sometimes I’m constipated and sometimes loose*. It is a defined stool-pattern category. [\[1\]](#cite-1 "Reference [1]") Minimal Testing, Not Minimal Thinking ------------------------------------- A positive diagnosis does **not** mean careless diagnosis. In patients with **diarrhea symptoms**, the ACG recommends **celiac serology** and suggests checking **fecal calprotectin or lactoferrin plus CRP** to help exclude IBD when alarm features are absent. It also recommends against routine stool pathogen panels in all IBS patients. This is a classic boards theme: if it looks like IBS-D, rule out the few common, consequential mimics first, then stop. Do not shotgun stool studies, food allergy panels, and repeated imaging. [\[1\]](#cite-1 "Reference [1]") On the constipation side, keep one diagnostic trap in mind: **pelvic floor dysfunction**. If the patient labeled as IBS-C has marked straining, incomplete evacuation, digital maneuvers, or constipation refractory to standard therapy, think beyond slow transit. The ACG suggests **anorectal physiology testing** when symptoms point to a pelvic floor disorder or when constipation is refractory. Board trap: dyssynergic defecation can coexist with IBS and will not improve because you increased fiber one more time. [\[1\]](#cite-1 "Reference [1]") When Colonoscopy Helps—and When It Does Not ------------------------------------------- This is the part clinicians often overcomplicate. The ACG recommends **against routine colonoscopy** in patients with IBS symptoms who are **younger than 45** and have **no warning signs**. Alarm features that should make you pause include **hematochezia, melena, unintentional weight loss, older age at symptom onset, or a family history of IBD, colon cancer, or other significant GI disease**. Separate that from cancer screening: in the U.S., average-risk adults should undergo colorectal cancer screening starting at **45**. So a 47-year-old with textbook IBS symptoms and no prior screening may need colon evaluation because of **screening age**, not because IBS itself demands a scope. [\[1\]](#cite-1 "Reference [1]") Equally high yield: if a patient older than 45 already had a **recent negative colonoscopy** and has **no new alarm features**, IBS symptoms alone do not justify repeating it. That restraint is not laziness; it is good care, and the 2025 AGA quality indicators reinforce avoidance of routine colonoscopy in IBS patients who do not otherwise meet CRC-screening criteria and lack alarm features. A useful nuance is the older patient—especially an **older woman with substantial watery diarrhea**—in whom microscopic colitis becomes more plausible and colonoscopy with biopsies may add value. [\[1\]](#cite-1 "Reference [1]") Clinical Correlations --------------------- In clinic, three patients teach the whole framework. First, the 29-year-old with constipation and bloating but no recurrent abdominal pain probably has **functional constipation**, not IBS-C. Second, the 33-year-old with classic IBS-D symptoms, normal inflammatory testing, and no alarm features does **not** need colonoscopy for reassurance. Third, the 48-year-old with identical symptoms but no prior CRC screening does need colon evaluation—but because they are at screening age. If you keep those three cases straight, you will avoid most diagnostic errors in IBS. [\[1\]](#cite-1 "Reference [1]") Key Takeaways ------------- - **Rome IV is still the practical exam and guideline framework as of April 2026**; Rome V is announced for **June 1, 2026**. [\[1\]](#cite-1 "Reference [1]") - **Recurrent abdominal pain is required** for Rome IV IBS. Constipation without pain points more toward functional constipation. [\[1\]](#cite-1 "Reference [1]") - **Subtype IBS using Bristol stool form on abnormal stool days**, ideally off bowel-active meds: IBS-C, IBS-D, IBS-M, or IBS-U. [\[1\]](#cite-1 "Reference [1]") - In **diarrhea-predominant symptoms**, check for **celiac disease** and use **CRP/fecal calprotectin or lactoferrin** to help exclude IBD. [\[1\]](#cite-1 "Reference [1]") - **Do not order routine colonoscopy** for patients **under 45** with typical IBS symptoms and no alarm features; do pursue colon evaluation for **red flags** or **age-appropriate CRC screening**. [\[1\]](#cite-1 "Reference [1]") Conclusion ---------- The mature Internal Medicine approach to IBS diagnosis is disciplined, not defensive: use **Rome IV**, subtype the stool pattern correctly, look for a few dangerous mimics, and reserve colonoscopy for the patients in whom it changes care. That is better medicine and better board strategy. [\[1\]](#cite-1 "Reference [1]") Frequently Asked Questions ---------------------------- Can I diagnose IBS-C if the patient has constipation and bloating but little or no pain? Not by **Rome IV**. Recurrent abdominal pain is required; without it, **functional constipation** is a better starting diagnosis. [\[1\]](#cite-1 "Reference [1]") Does every patient with suspected IBS-D need colonoscopy? No. Patients **younger than 45** without alarm features usually do not need routine colonoscopy, though they still need targeted testing for celiac disease and IBD mimics. Screening-related colon evaluation starts at **45** for average-risk adults. [\[1\]](#cite-1 "Reference [1]") How should I subtype IBS if the patient uses laxatives or antidiarrheals? Classify stool pattern **off bowel-active therapy when possible** and judge Bristol stool form only on **abnormal stool days**; a short stool diary improves accuracy. [\[1\]](#cite-1 "Reference [1]") When should pelvic floor testing enter the workup of presumed IBS-C? Think about anorectal physiology testing when constipation is **refractory** or when symptoms suggest an **evacuation disorder** such as marked straining, incomplete evacuation, or need for manual maneuvers. [\[1\]](#cite-1 "Reference [1]") References (5) ------------------ 1. 1. [ webfiles.gi.org/links/PCC/ACG\_Clinical\_Guideline\_\_Management\_of\_Irritable.11.pdf ](https://webfiles.gi.org/links/PCC/ACG_Clinical_Guideline__Management_of_Irritable.11.pdf) [↩](#cite-ref-1-1 "Back to text") 2. 2. Lacy BE, Pimentel M, Brenner DM, et al. ACG Clinical Guideline: Management of Irritable Bowel Syndrome. American Journal of Gastroenterology. 2021. 3. 3. U.S. Preventive Services Task Force. Colorectal Cancer: Screening. 4. 4. AGA Institute Quality Indicator Development for Irritable Bowel Syndrome. Gastroenterology. 2025. 5. 5. Rome Foundation. Rome V: A Global Framework for Disorders of Gut–Brain Interaction. Study pathway Turn reading into Internal Medicine performance ------------------------------------------------- - System‑based, exam‑style questions + explanations - Smarter review to reinforce weak topics - Build confidence with measurable progress Free 5-day trial No credit card required. [ Start practicing ](https://mdster.com/user/dashboard) [ Explore Internal Medicine ](https://mdster.com/speciality/internal-medicine) [ View pricing ](https://mdster.com/pricing) [ Explore features ](https://mdster.com/features) No credit card required. Full access to all features. No commitment. Cancel anytime. [ Back to all posts ](https://mdster.com/blog) Discussion () ----------------- Join the discussion [ Log in ](https://mdster.com/auth/login) or [ Sign up ](https://mdster.com/auth/register) No comments yet Be the first to share your thoughts! ![]() Related Posts ------------- [ ![Anxiety, Depression, and Breathlessness in Severe COPD/Asthma Overlap](https://mdster.com/storage/blog/images/anxiety-depression-and-breathlessness-in-severe-copdasthma-overlap.jpg) Medical Education ### Anxiety, Depression, and Breathlessness in Severe COPD/Asthma Overlap A focused Family Medicine review of anxiety, depression, and dyspnea in severe COPD/asthma overlap, with safer prescribing, breathing retraining, and board-style pitfalls. 6 min read 0 comments ](https://mdster.com/blog/anxiety-depression-and-breathlessness-in-severe-copdasthma-overlap) [ ![Neonatal Septic Shock in the ED: A High-Yield Case Discussion](https://mdster.com/storage/blog/images/neonatal-septic-shock-in-the-ed-a-high-yield-case-discussion.jpg) Case Discussion ### Neonatal Septic Shock in the ED: A High-Yield Case Discussion An ill 18-day-old with fever, lethargy, shock, and hypoglycemia demands parallel resuscitation and sepsis management. This case reviews ED priorities, LP timing, antibiotics, HSV coverage, and board pearls. 6 min read 0 comments ](https://mdster.com/blog/neonatal-septic-shock-in-the-ed-a-high-yield-case-discussion) [ ![Congenital Hypothyroidism: Screening, Levothyroxine, Outcomes](https://mdster.com/storage/blog/images/congenital-hypothyroidism-screening-levothyroxine-outcomes.jpg) Medical Education ### Congenital Hypothyroidism: Screening, Levothyroxine, Outcomes High-yield review of congenital hypothyroidism for Pediatrics trainees, covering newborn screening pitfalls, urgent levothyroxine treatment, and developmental follow-up. 6 min read 0 comments ](https://mdster.com/blog/congenital-hypothyroidism-screening-levothyroxine-outcomes) [ ](/) Master your medical exams with evidence-based learning. [ GET IT ON Google Play ](https://play.google.com/store/apps/details?id=com.mdster.app) ### Platform - [Home](https://mdster.com) - [Features](https://mdster.com/features) - [Pricing](https://mdster.com/pricing) - [About](https://mdster.com/about) ### Resources - [Blog](https://mdster.com/blog) - [Dashboard](https://mdster.com/user/dashboard) ### Support - [Contact](https://mdster.com/contact) - [Legal & Policies](https://mdster.com/legal) - [Medical Reviewers](https://mdster.com/medical-reviewers) © 2026 MDster [ ](https://play.google.com/store/apps/details?id=com.mdster.app) [Terms](https://mdster.com/terms) [Privacy](https://mdster.com/privacy) [Editorial](https://mdster.com/editorial-policy) reCAPTCHA Protected by reCAPTCHA. Google [Privacy Policy](https://policies.google.com/privacy) and [Terms of Service](https://policies.google.com/terms) apply. Cookie Consent -------------- We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. [ Terms of Use ](https://mdster.com/terms) & [ Privacy Policy ](https://mdster.com/privacy) Accept